Y-Intercept (HK)’s OnKure Therapeutics OKUR Stock Holding History

Y-Intercept (HK)’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-11,288	Closed	-$51.5K	–	2194
2026 Q2	$51.5K	Buy	+11,288	New	+$48.4K	﹤0.01%	1624
2024 Q3	–	Sell	-5,568	Closed	-$84.1K	–	1895
2024 Q2	$84.1K	Buy	+5,568	New	+$94.4K	﹤0.01%	1274

Other funds holding OKUR

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Y-Intercept (HK)'s OKUR Position: Q3 2026 in Review

Y-Intercept (HK) sold out of OnKure Therapeutics (OKUR) in Q3 2026, closing a stake of 11,288 shares — an estimated $51.5K sold.

Y-Intercept (HK) first reported a position in OKUR in Q2 2024 and held it in 2 quarters. The position peaked at $84.1K in Q2 2024. 2 funds tracked by Wall St. Rank hold OKUR as of Q3 2026.

Y-Intercept (HK) reported no remaining OnKure Therapeutics position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 11,288 OnKure Therapeutics shares in Q3 2026, an estimated $51.5K.
Y-Intercept (HK) first reported a position in OnKure Therapeutics in Q2 2024 and held it in 2 quarters.
Y-Intercept (HK)'s OnKure Therapeutics position peaked at $84.1K in Q2 2024.
2 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.